Skip to main content
Top
Published in: Journal of Cancer Education 1/2018

01-02-2018

Evaluation of Association Between Gynecologic Oncology Fellowship Length and a Career in Academic Medicine

Authors: Joshua P. Kesterson, J. Brian Szender, Eric Schaefer, James Fanning, Shashikant Lele, Peter Frederick

Published in: Journal of Cancer Education | Issue 1/2018

Login to get access

Abstract

The purpose of this study is to determine the association between gynecologic oncology fellowship training factors, including fellowship length, and a career in academic medicine. A survey was sent to all 980 gynecologic oncologists identified via the SGO membership directory. The survey questions focused on demographics, fellowship training, practice- type, and research involvement. Demographics of the study population and survey responses were reported using frequencies and percentages. Chi-squared tests were used to test for associations between selected survey responses and length of fellowship. The authors received 410 (42 %) responses. Most respondents (60 %) graduated from a 3-year fellowship, while 27 and 13 % attended 2- and 4-year fellowships, respectively. Practice descriptions included academic/university (52 %), community/private practice (21 %), private practice with academic appointment (20 %), and other (7 %). A majority (64 %) reported current involvement in research as a principal investigator (PI); however, 54 % reported spending 10 % or less of their time in research-related activities. Approximately half reported that their fellowship research experience contributed to their current practice. Graduates of 3- and 4-year fellowships had similar rates of employment in academic/university settings (58 and 52 %, respectively). Graduates of 4-year fellowships were more likely to hold an advanced degree and 11 or more publications at completion of fellowship. A majority of graduates of a gynecologic oncology fellowship practice in an academic/university setting and are involved in research. Fellowship length does not correlate with a current academic medicine appointment. Graduates of 4-year fellowships are more likely to hold additional advanced degrees and more publications.
Literature
1.
go back to reference Scribner RD Jr, Baldwin J, Gold MA (2001) Factors affecting fellowship satisfaction among gynecologic oncology fellows. Gynecol Oncol 80:74–78CrossRefPubMed Scribner RD Jr, Baldwin J, Gold MA (2001) Factors affecting fellowship satisfaction among gynecologic oncology fellows. Gynecol Oncol 80:74–78CrossRefPubMed
2.
go back to reference Lyle JL, Vandergrift JL, Hinkel JM, Lepisto EM, Cortazzo KA, Sherman S, Stewart FM (2012) Influential factors for post-fellowship career decision-making: an NCCN survey. J Natl Compr Cancer Netw 10:969–974CrossRef Lyle JL, Vandergrift JL, Hinkel JM, Lepisto EM, Cortazzo KA, Sherman S, Stewart FM (2012) Influential factors for post-fellowship career decision-making: an NCCN survey. J Natl Compr Cancer Netw 10:969–974CrossRef
4.
go back to reference Eisenkop SM, Spirtos NM (2004) The relative importance of surgical training and laboratory research in a gynecologic oncology fellowship. Int J Gynecol Cancer 14:23–24CrossRefPubMed Eisenkop SM, Spirtos NM (2004) The relative importance of surgical training and laboratory research in a gynecologic oncology fellowship. Int J Gynecol Cancer 14:23–24CrossRefPubMed
5.
go back to reference Wang Y, Beydoun MA (2007) The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29:6–28CrossRefPubMed Wang Y, Beydoun MA (2007) The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29:6–28CrossRefPubMed
Metadata
Title
Evaluation of Association Between Gynecologic Oncology Fellowship Length and a Career in Academic Medicine
Authors
Joshua P. Kesterson
J. Brian Szender
Eric Schaefer
James Fanning
Shashikant Lele
Peter Frederick
Publication date
01-02-2018
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 1/2018
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-016-1043-0

Other articles of this Issue 1/2018

Journal of Cancer Education 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine